BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Treatment
152 results:

  • 1. Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/ERK and stat3/c-Myc Pathways.
    Wang C; Wang B; Mou Y; Liu X; Chen Q; Pu W; Rao Q; Wang C; Song J; Huang Y; Yan L; Huang L; Li Y
    Molecules; 2024 Apr; 29(7):. PubMed ID: 38611876
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.
    Das J; Bera S; Ganguly N; Guha I; Ghosh Halder T; Bhuniya A; Nandi P; Chakravarti M; Dhar S; Sarkar A; Das T; Banerjee S; Ghose S; Bose A; Baral R
    Front Immunol; 2024; 15():1325161. PubMed ID: 38585261
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Gentiopicroside ameliorates the lipopolysaccharide-induced inflammatory response and hypertrophy in chondrocytes.
    Li L; Fan Q; Zhao Y; Zhang Q; Qin G; Li C; Li W
    J Orthop Surg Res; 2024 Mar; 19(1):198. PubMed ID: 38528538
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
    Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
    Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines.
    Wu Y; Wang V; Yarchoan R
    Sci Rep; 2024 Feb; 14(1):4125. PubMed ID: 38374336
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets.
    Liu Y; Jiang B; Li Y; Zhang X; Wang L; Yao Y; Zhu B; Shi H; Chai X; Hu X; Zhang B; Li H
    Medicine (Baltimore); 2024 Jan; 103(3):e36467. PubMed ID: 38241548
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A study protocol for an open-label, single-arm, single-center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma.
    Huang H; Zhang H; Cao B
    Thorac Cancer; 2024 Feb; 15(5):427-433. PubMed ID: 38211967
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Activation of HDAC8 Can Suppress the Proliferation of Osteosarcoma Cells via
    Wang L; Bai X; Zhang X; Wang X; Chen S; Wu S; Lin L
    Ann Clin Lab Sci; 2023 Nov; 53(6):920-930. PubMed ID: 38182151
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Morin inhibits osteosarcoma migration and invasion by suppressing urokinase plasminogen activator through a signal transducer and an activator of transcription 3.
    Yang JS; Chou CH; Hsieh YH; Lu PW; Lin YC; Yang SF; Lu KH
    Environ Toxicol; 2024 Apr; 39(4):2024-2031. PubMed ID: 38093596
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Bazedoxifene Suppresses the Growth of Osteosarcoma Cells by Inhibiting IL-6 and IL-11/GP130 Signaling Pathway.
    Wu X; Cao Y; Xiao H; Feng J; Lin J
    J Pediatr Hematol Oncol; 2024 Jan; 46(1):8-14. PubMed ID: 37962127
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Eicosapentaenoic acid enhances the sensitivity of osteosarcoma to cisplatin by inducing ferroptosis through the DNA-PKcs/AKT/NRF2 pathway and reducing PD-L1 expression to attenuate immune evasion.
    Zhang Y; Shen G; Meng T; Lv Z; Li X; Li J; Li K
    Int Immunopharmacol; 2023 Dec; 125(Pt B):111181. PubMed ID: 37951196
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of stat3/CCL2 signaling pathway in uterine sarcoma.
    Hwang JR; Cho YJ; Ryu JY; Choi JY; Choi JJ; Sa JK; Kim HS; Lee JW
    Biomed Pharmacother; 2023 Dec; 168():115792. PubMed ID: 37924789
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
    Sohel M
    Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Possible Role of IL-6R/stat3/MiRNA-34a Feedback Loop in Osteosarcoma.
    Amer MF; Mohamed A; Ismail A; Bayoumi LA; Shibel PEE; Elnaggar GN
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3269-3274. PubMed ID: 37774081
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Network pharmacology and molecular docking to explore the mechanism of Sheng Xue Bao mixture against iron deficiency anemia.
    Wang Y; Qinqin H; Wang H; Zhang H; Zhang X; Liu W; Xiang Z; Gu Y
    Medicine (Baltimore); 2023 Sep; 102(37):e35012. PubMed ID: 37713882
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Circular RNAs in osteosarcoma: An update of recent studies (Review).
    Zeng L; Liu L; Ni WJ; Xie F; Leng XM
    Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37681483
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2/stat3 Pathway.
    Zhu WT; Zeng XF; Yang H; Jia ML; Zhang W; Liu W; Liu SY
    Int J Nanomedicine; 2023; 18():2677-2691. PubMed ID: 37228445
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cold plasma and inhibition of stat3 selectively target tumorigenicity in osteosarcoma.
    Tornín J; Mateu-Sanz M; Rey V; Murillo D; Huergo C; Gallego B; Rodríguez A; Rodríguez R; Canal C
    Redox Biol; 2023 Jun; 62():102685. PubMed ID: 36989573
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Tumor-associated macrophages induce inflammation and drug resistance in a mechanically tunable engineered model of osteosarcoma.
    Chim LK; Williams IL; Bashor CJ; Mikos AG
    Biomaterials; 2023 May; 296():122076. PubMed ID: 36931102
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Fluoxetine Inhibits stat3-mediated Survival and Invasion of Osteosarcoma Cells.
    Chen WT; Tsai YH; Tan P; Hsu FT; Wang HD; Lin WC; Lin FH; Wu CT
    Anticancer Res; 2023 Mar; 43(3):1193-1199. PubMed ID: 36854535
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.